HOMEBIOGAS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 340.5 ILa | -0.23% |
|
-.--% | -13.29% |
| Mar. 20 | HomeBiogas Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | HomeBiogas Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 69.46 | 34.47 | 21.35 |
| Enterprise Value (EV) 1 | 45.39 | 24.91 | 14.16 |
| P/E ratio | -8.06 x | -2.28 x | -2.18 x |
| Yield | - | - | - |
| Capitalization / Revenue | 28 x | 7.33 x | 4.42 x |
| EV / Revenue | 18.3 x | 5.3 x | 2.93 x |
| EV / EBITDA | -5.03 x | -1.88 x | -1.35 x |
| EV / FCF | -6,208,608 x | -3,298,009 x | -1,990,697 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 2.47 x | 2.4 x | 1.86 x |
| Nbr of stocks (in thousands) | 19,590 | 19,590 | 19,635 |
| Reference price 2 | 3.546 | 1.760 | 1.087 |
| Announcement Date | 3/23/22 | 3/15/23 | 3/20/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.385 | 1.471 | 1.016 | 2.482 | 4.701 | 4.831 |
| EBITDA 1 | -1.523 | -1.915 | -3.886 | -9.026 | -13.25 | -10.51 |
| EBIT 1 | -1.544 | -1.954 | -3.929 | -9.192 | -13.6 | -10.91 |
| Operating Margin | -111.48% | -132.83% | -386.71% | -370.35% | -289.41% | -225.79% |
| Earnings before Tax (EBT) 1 | -1.554 | -1.985 | -4.216 | -8.29 | -15.16 | -11.33 |
| Net income 1 | -1.576 | -2.003 | -4.222 | -8.311 | -15.16 | -11.34 |
| Net margin | -113.79% | -136.17% | -415.55% | -334.85% | -322.57% | -234.63% |
| EPS 2 | -41.52 | -54.07 | -0.4166 | -0.4400 | -0.7732 | -0.4980 |
| Free Cash Flow | - | -2.268 | -1.929 | -7.311 | -7.552 | -7.112 |
| FCF margin | - | -154.21% | -189.87% | -294.57% | -160.64% | -147.22% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 1/26/21 | 1/26/21 | 3/24/21 | 3/23/22 | 3/15/23 | 3/20/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 2.87 | 1.35 | 6.51 | 24.1 | 9.56 | 7.19 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -2.27 | -1.93 | -7.31 | -7.55 | -7.11 |
| ROE (net income / shareholders' equity) | - | -140% | -114% | -48.3% | -71.4% | -79.8% |
| ROA (Net income/ Total Assets) | - | -35.3% | -40.4% | -27% | -32% | -34.9% |
| Assets 1 | - | 5.668 | 10.45 | 30.76 | 47.43 | 32.46 |
| Book Value Per Share 2 | 40.30 | 22.40 | 139.0 | 1.430 | 0.7300 | 0.5800 |
| Cash Flow per Share 2 | 40.70 | 12.90 | 148.0 | 1.330 | 0.5700 | 0.3800 |
| Capex 1 | 0.09 | 0.12 | 0.1 | 0.7 | 0.79 | 0.55 |
| Capex / Sales | 6.79% | 7.89% | 9.35% | 28.2% | 16.78% | 11.3% |
| Announcement Date | 1/26/21 | 1/26/21 | 3/24/21 | 3/23/22 | 3/15/23 | 3/20/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -13.29% | 21.84M | |
| +22.57% | 171B | |
| +34.73% | 31.82B | |
| +26.65% | 31.45B | |
| -19.34% | 27.01B | |
| +29.83% | 23.66B | |
| -7.77% | 12.48B | |
| -8.02% | 10.5B | |
| +118.80% | 9.62B | |
| +39.31% | 5.97B |
- Stock Market
- Equities
- HMGS Stock
- Financials HomeBiogas Ltd
